Issue link: http://deals.uberflip.com/i/1535917
SPECIALIZED THIRD‐PARTY MEDICAL BILLING AND SCHEDULING SERVICES COMPANY Northeastern US #68238 BUSINESS HIGHLIGHTS This dynamic and innovave company specializes in comprehensive scheduling and third‐party medical billing services within the Workers' Compensaon sector by ensuring seamless communicaon and efficient service delivery between healthcare providers and facilies. With a commitment to compeve pricing, superior provider relaons, and advanced proprietary soware, the Company stands out as a leader in the industry, dedicated to enhancing operaonal efficiency and client sasfacon. The Company's extensive scheduling and billing offerings effecvely coordinate diagnosc tesng, durable medical equipment, hearing aids, and home health services for those in the Worker's Compensaon space. Acng as a liaison between doctors and diagnosc facilies, the Company ensures mely appointments and regular status reports on scheduling and billing. The Company priorizes efficient claim verificaon, custom reporng, and electronic billing to achieve beer outcomes for paents and physicians. The Company's excellent industry reputaon and brand awareness has established it as a leading scheduling and billing provider in the region to healthcare providers, insurance carriers, and third‐party administrators. The Company's proprietary soware enhances customer experience through mely communicaon and opmal resource allocaon, while key performance indicators help refine strategies and improve operaonal efficiency. The Company's client base is composed of 650+ acve accounts with a 97% rate of repeat business, ensuring high‐quality service delivery. Leveraging its strategic growth opportunies, robust service offerings, and unique business model, the Company is posioned for connued success and market expansion. Moses Shmueli Managing Director ‐ M&A E. mshmueli@generational.com T. 212‐401‐7962 INVESTMENT BANK OF THE YEAR 2016 - 2017 - 2018 - 2022 - 2024 DISCLAIMER: All informaon contained in this document has been provided by the subject company to Generaonal Equity and while believed to be correct has not been verified. Accordingly, Generaonal Equity makes no representaons or warranes as to the accuracy and truthfulness of such informaon. The recipient hereof acknowledges that Generaonal Equity shall not be liable for any loss or injury suffered by said recipient in any way connected to the delivery by Genera‐ onal Equity of this document. At all mes Generaonal Equity and/or its affiliate network members are agents for the seller and not for the buyer. Generaonal Equity's fees are paid by the seller. REVENUE / EBITDA INVESTMENT APPEAL Advanced Proprietary Soware. The Company's proprietary scheduling and billing soware, developed in‐house, automates the coordinaon of appointments and streamlines communicaon between doctors and diagnosc facilies. This soware dynamically adjusts schedules based on various factors, ensuring efficient resource allocaon and mely service delivery. Direct Provider Engagement: The Company directly partners with medical providers rather than primarily engaging with insurance providers. This unique approach allows the Company to offer stronger reimbursements, fostering loyalty and trust among providers. Priorizing provider sasfacon ensures a movated network of high‐quality healthcare professionals, leading to beer paent service. Comprehensive Service Offering: The Company provides scheduling for a wide range of diagnosc tesng services including MRI, PT with/without contrast, EMG, X‐rays, ultrasounds, bone density scans, and extended radiology. This extensive porolio ensures that paents receive mely and appropriate care, improving overall paent outcomes. Coupled with its broad range of services, the Company ensures comprehensive support for injured workers. Strong Historical Sales Growth. Historical sales increased from $3,9230,000 in 2022 to $10,827,000 in 2024, represenng a compound annual growth rate of 66.1%. Sales have grown consistently year over year in the historical period. Generaonal Equity 125 Park Avenue , 25th Floor New York, NY 10017 SIGN NDA ► $17.5M Projected 2025 Revenue $1.6M Projected 2025 EBITDA $10.8M 2024 Revenue $877K 2024 EBITDA REVENUE SOURCES MRI 74% EMG 20% CT 3% Other Radiology 2% DME/Hearing Aids 1% CUSTOMER MARKETS Contracted Diagnosc Facilies 40% Carriers 35% Physicians 24% Medical Good Suppliers 1% FINANCIAL PERFORMANCE